Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Okayama University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Okayama University
ClinicalTrials.gov Identifier:
NCT01198340
First received: September 8, 2010
Last updated: July 20, 2011
Last verified: August 2010

September 8, 2010
July 20, 2011
September 2010
March 2012   (final data collection date for primary outcome measure)
pain scores by use of numerous rating scale (NRS) [ Time Frame: 4 days after the surgery ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01198340 on ClinicalTrials.gov Archive Site
dose of local anesthetics [ Time Frame: 4 days after the surgery ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block
Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block With Sciatic Nerve Block After Total Knee Arthroplasty

To evaluate an analgesic effect without basal administration of local anesthetics for patient-controlled femoral nerve block (with sciatic nerve block) after total knee arthroplasty.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Arthropathy of Knee Joint
  • Procedure: PC-FNB with basal administration of local anesthetics
    Administration of 0.2% ropivacaine for femoral nerve block with 3 ml/h of basal dose, 5ml bolus by the patient, 60 minutes of lock out time.
    Other Name: PC-FNB with basal ropivacaine administration
  • Procedure: PC-FNB without basal local anesthetics
    Administration of 0.2% ropivacaine for femoral nerve block without basal dose, with 8 ml bolus by the patient, 60 minutes of lockout time.
    Other Name: PC-FAB without basal ropivacaine administration
  • Active Comparator: With basal local anesthetics
    Intervention: Procedure: PC-FNB with basal administration of local anesthetics
  • Experimental: Without basal local anesthetics
    Intervention: Procedure: PC-FNB without basal local anesthetics
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
June 2012
March 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients older than 20 yrs old scheduled for total knee arthroplasty

Exclusion Criteria:

  • none
Both
20 Years and older
No
Contact: Hideki Taninishi, MD, PhD 81-86-235-7327 tanishi@ops.dti.ne.jp
Japan
 
NCT01198340
TKAFEMORAL-2010, UMIN000004155
Yes
Hideki Taninishi, Okayama University Medical School
Okayama University
Not Provided
Principal Investigator: Hideki Taninishi, MD, PhD Okayama University
Okayama University
August 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP